NTB Financial’s Merck MRK Stock Holding History

NTB Financial’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$423K	Sell	4,642 -168	-3%	-$14.9K	0.34%	86
2022 Q1	$395K	Hold	4,810	–	–	0.28%	90
2021 Q4	$369K	Buy	+4,810	New	+$383K	0.26%	92

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

NTB Financial's MRK Position: Q2 2022 in Review

NTB Financial reduced its Merck (MRK) stake by 3.5% in Q2 2022, selling an estimated $14.9K and leaving 4,642 shares worth $423K. The position accounts for 0.34% of the portfolio, ranked #86.

NTB Financial first reported a position in MRK in Q4 2021 and has held it in 3 quarters since. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

NTB Financial held 4,642 shares of Merck worth $423K as of Q2 2022.
NTB Financial sold 168 Merck shares in Q2 2022, an estimated $14.9K.
Merck made up 0.34% of NTB Financial's portfolio in Q2 2022, its #86 holding.
NTB Financial first reported a position in Merck in Q4 2021 and has held it in 3 quarters since.
3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.